Location: Yorkshire and Humber
Location: East Midlands
Location: Avon Gloucester and Wiltshire
A new blood test that focuses on biomarkers could be used to diagnose Alzheimer's along with other hard-to-identify conditions years before the onset of symptoms, scientists have said.
Research, published in journal Cell, detailed the usage of synthetic molecules to identify antibodies that are specific to Alzheimer's disease.
Additionally, the research could be used in future cases to detect conditions such as multiple sclerosis, lupus and Parkinson's disease.
"One of the great challenges in treating patients with Alzheimer's disease is that once symptoms appear, it's too late. You can't un-ring the bell," said Dr Dwight German, author of the study.
"If we can find a way to detect the disease in its earliest stages - before cognitive impairment begins - we might be able to stop it in its tracks by developing new treatment strategies," he added.
This comes after research published in journal PLoS ONE found that two pathways associated with neurodegenerative diseases were linked to rare childhood disease Lesch-Nyhan Disease (LND).
Written by Martin Lambert
Andover War Memorial Hospital in Hampshire has announced that it intends to recruit more staff to help cope...
Scientists working on behalf of Cancer Research UK have developed a new method of tracking how tumours evolve...
A new pilot scheme aimed at transforming the way in which blood stocks are kept and delivered has now been...
Researchers in the UK claim to have developed a blood test that could be used in order to help diagnose the early...